Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria

被引：92
作者：
Straesser, Matthew D. [1 ]
Oliver, Eric [2 ]
Palacios, Thamiris [1 ]
Kyin, Timothy [1 ]
Patrie, James [3 ]
Borish, Larry [1 ,4 ]
Saini, Sarbjit S. [2 ]
Lawrence, Monica G. [1 ]
机构：
[1] Univ Virginia Hlth Syst, Div Allergy & Clin Immunol, Box 801355, Charlottesville, VA 22908 USA
[2] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD USA
[3] Univ Virginia, Div Publ Hlth Sci, Charlottesville, VA USA
[4] Univ Virginia Hlth Syst, Div Microbiol, Charlottesville, VA 22908 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2018年 / 6卷 / 04期
关键词：
D O I：
10.1016/j.jaip.2017.10.030
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1386 / +
页数：4
相关论文
共 10 条
[1]   IgE Mediated Autoallergy against Thyroid Peroxidase - A Novel Pathomechanism of Chronic Spontaneous Urticaria? [J].
Altrichter, Sabine ;
Peter, Hans-Juergen ;
Pisarevskaja, Dina ;
Metz, Martin ;
Martus, Peter ;
Maurer, Marcus .
PLOS ONE, 2011, 6 (04)
[2]   Omalizumab-induced reductions in mast cell FcεRI expression and function [J].
Beck, LA ;
Marcotte, GV ;
MacGlashan, D ;
Togias, A ;
Saini, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530
[3]   The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change [J].
Ertas, R. ;
Ozyurt, K. ;
Atasoy, M. ;
Hawro, T. ;
Maurer, M. .
ALLERGY, 2018, 73 (03) :705-712
[4]   Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria [J].
Kaplan, Allen ;
Ferrer, Marta ;
Bernstein, Jonathan A. ;
Antonova, Evgeniya ;
Trzaskoma, Benjamin ;
Raimundo, Karina ;
Rosen, Karin ;
Omachi, Theodore A. ;
Khalil, Sam ;
Zazzali, James L. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) :474-481
[5]   Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria [J].
Maurer, Marcus ;
Rosen, Karin ;
Hsieh, Hsin-Ju ;
Saini, Sarbjit ;
Grattan, Clive ;
Gimenez-Arnau, Ana ;
Agarwal, Sunil ;
Doyle, Ramona ;
Canvin, Janice ;
Kaplan, Allen ;
Casale, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :924-935
[6]   Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysis [J].
Metz, Martin ;
Ohanyan, Tatevik ;
Church, Martin K. ;
Maurer, Marcus .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 73 (01) :57-62
[7]   Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria [J].
Palacios, Thamiris ;
Stillman, Leland ;
Borish, Larry ;
Lawrence, Monica .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (03) :529-530
[8]   Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature [J].
Tonacci, Alessandro ;
Billeci, Lucia ;
Pioggia, Giovanni ;
Navarra, Michele ;
Gangemi, Sebastiano .
PHARMACOTHERAPY, 2017, 37 (04) :464-480
[9]   Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria [J].
Viswanathan, Ravi K. ;
Moss, Mark H. ;
Mathur, Sameer K. .
ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (05) :446-452
[10]  
Zheng Y, 2014, AM ASS PHARM SCI NAT
1